Phosphate buffer solution: Clinical Trials

2 trials of Phosphate buffer solution, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 21Completed 1

Follow Phosphate buffer solution: new trials by email Literature Review of Phosphate buffer solution trials Research Report on Phosphate buffer solution

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above.
Quadrivalent influenza virus split vaccine (MDCK cells), Quadrivalent influenza virus split vaccine (Chicken embryo), Phosphate buffer solution - Influenza
Phase 1CompletedShanghai Institute Of Biological Products3002024-03-302025-02-19
A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza Vaccine
7.5μg H7N9 Vaccine, Phosphate Buffer Solution, Aluminum Hydroxide Adjuvant - H7N9 Influenza
Phase 1 / Phase 2CompletedShanghai Institute Of Biological Products3602017-12-292024-10-15

Conditions studied

Influenza, Human (1)

Sponsors

Shanghai Institute Of Biological Products (2)

Countries

China (2)

Top investigators

Guohua Li (1)  ·  Ze Chen, PhD (1)